Clinical Trials Logo

Clinical Trial Summary

This longitudinal observational cohort study was designed to investigate factors that influencing the occurrence and long-term survival of patients with primary liver cancer. Basic informations and detailed diagnosis informations (AJCC/TNM stage, MELD score, Child-Pugh score, and BCLC stage) were collected by professional doctors. Clinical outcomes (death, recurrence, and metastasis) will be followed up every two years after therapy.


Clinical Trial Description

Primary liver cancer (PLC) is highly malignant with high mortality which is particularly popular in China. Many factors are believed to associate with the occurrence and prognosis of liver cancer. This longitudinal observational cohort study was designed to investigate factors that influencing the occurrence and long-term survival of patients with primary liver cancer. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03297255
Study type Observational
Source Sun Yat-sen University
Contact Zhu Huilian, Professor
Phone +86 20 87331811
Email zhuhl@mail.sysu.edu.cn
Status Recruiting
Phase N/A
Start date January 1, 2013
Completion date December 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03161925 - Chinese Liver Cancer Clinical Survey N/A
Completed NCT00261378 - Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation Phase 2
Enrolling by invitation NCT05609448 - MRI-guided Holmium-166 Radioembolization N/A
Recruiting NCT05714124 - Liver Embolization Approaches for Tumor Management
Not yet recruiting NCT05353894 - Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers Phase 1
Completed NCT03518632 - Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer (APACHE) N/A
Terminated NCT00003530 - Antineoplaston Therapy in Treating Patients With Primary Liver Cancer Phase 2
Recruiting NCT04806464 - Clinical Study of VG161 in Subjects With Advanced Primary Liver Cancer Phase 1
Recruiting NCT06342414 - An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Completed NCT01116804 - Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC) Phase 1
Recruiting NCT03067493 - RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial Phase 2
Completed NCT05183776 - Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT N/A
Recruiting NCT05677724 - Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment
Not yet recruiting NCT03178929 - Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma N/A
Recruiting NCT05267080 - Registry on Percutaneous Electrochemotherapy
Not yet recruiting NCT02327819 - The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer N/A
Completed NCT01640522 - Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms N/A
Completed NCT00408122 - Evaluation of Preoperative Investigations in Patients With Liver Cancer N/A
Recruiting NCT06325267 - Clinical Characteristics of Primary Liver Cancer
Completed NCT04295330 - Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy N/A